Trial Profile
Comparision of ESLAX Intravenous with Rocuronium Bromide Intravenous Solution in the incident of pain on injection
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 08 Jul 2019
Price :
$35
*
At a glance
- Drugs Rocuronium bromide (Primary)
- Indications Muscle hypertonia
- Focus Adverse reactions
- 03 May 2019 Status changed from not yet recruiting to completed.
- 08 May 2018 New trial record